Monday, March 19, 2018
Facebook - MedRecallNews Facebook - MedRecallNews Twitter - MedRecalls
Toll Free: 1-866-321-3585

Past Recalls -


Accutane removed from market

Acne medication linked to Crohn's Disease and other health issues

Woman head in hands in painAccutane has been linked to serious side effects including Crohn's Disease and Ulcerative Colitis. If you or a loved one has used Accutane and been injured due to the use of the drug you may be entitled to substantial financial compensation. Fill out the form on the page to receive a free confidential case evaluation.

In June 2009, Roche Pharmaceuticals, the maker of Accutane, said it was no longer making the drug due in large part to the increasing costs of defending lawsuits filed by users who were injured by Accutane.

The use of Accutane has been associated with the following types of Gastrointestinal Injuries: Inflammatory Bowel Disease, Crohn's Disease Ulcerative Colitis, and Rectal Bleeding.

From 1997 to 2002, the Food and Drug Administration received 85 reports of Inflammatory Bowel Disease it associated with the use of Accutane. In nearly all the cases, the agency determined it was "high probable" or "probable" that Accutane had caused the patients to develop the disease.

Since that time the amount of cases has grown substantially. Consolidated Accutane litigation started small, with just a few dozen Plaintiffs involved when Federal Multidistrict Litigation (MDL) was approved. The litigation has swelled as victims of Accutane side effects have won millions of dollars in damages in large part because health problems linger for years after users discontinue Accutane.

On May 14, the New Jersey state judiciary released a case list revealing 3,268 former Accutane users have enlisted an Accutane lawyer to file a lawsuit in the District.

In some recent medical studies in the U.S. and in England has many research Scientist evaluating the link between the use of Accutane and Crohn's Disease. Crohn's Disease affects the Bowels and can cause numerous problems in the lower Abdomen. This disease is in a group of illness called Inflammatory Bowel Disease (IBD).

Other Accutane Side Effects:

According to recent reports, some of those side effects include impaired night vision, Inflammatory Bowl Disease, Pancreatitis, Hypertension, Back pain, Nose bleeds, Nail changes, itiching, and even Hepatitis. Additionally, Alopecia (hair loss), Keloids (Cartilage degeneration), and Depression have been noted even after discontinuing Accutane treatment. An FDA-related study also suggests that there may be a link between Accutane use and suicidal tendencies, thoughts, or actions.

Accutane and Birth Defects:

When initially introduced, Accutane birth defects were not studied closely. As more pregnant women began taking Accutane to treat their Acne many of them had miscarriages or gave birth to infants with birth defects. Now, Accutane pregnancy defects are closely studied and women who are planning to get pregnant are not prescribed Accutane. If you were took Accutane while pregnant and your child was born with health defects we are here to help.

The most frequent Accutane birth defects pregnant women face are: Visual impairment, Deformities, Hearing impairment and/or missing Earlobes, Facial malformations, Glandular and Central Nervous System malformations, Mental retardation, and Heart defects. Along with the needless pain children are suffering from these side effects there are the very real concerns about the ongoing medical costs and care to treat children with such serious conditions.

To learn more about your legal rights, and further details about Accutane, please call or submit the evaluation form.



Darvon removed from market

Pain Killer linked to life threatening Heart problems

For 50 years Americans have taken Darvon/Darvocet (Propoxyphene) for pain. No one imagined that the "Pain Killer" could kill. But in November 2010 Darvon was removed from the market after the FDA announced:

FDA-LogoThe FDA sought market withdrawal of Propoxyphene after receiving new clinical data showing that the drug puts Patients at risk of potentially serious or even fatal heart rhythm abnormalities. As a result of these data, combined with other information, including new Epidemiological data, the agency concluded that the risks of the medication outweigh the benefits.

Darvon/Darvocet causes significant changes to the electrical activity of the heart. These changes, which can be seen on an Electrocardiogram (ECG), can increase the risk for serious abnormal Heart rhythms that have been linked to serious adverse effects, including sudden death. In a memo posted on the FDA's website, the agency said it is not possible to monitor for or mitigate the risk of a fatal Cardiac Arrhythmia that might occur at the recommended dose of Propoxyphene. In plain English - Darvon is not worth the risk!

If you or a loved suffered an unusual cardiac event with serious health consequences we can help you begin to evaluate whether Darvon or Darvocet played a factor in that health matter. MedRecallNews is here to help if you believe you may have been a victim of this medication.

To learn about your legal rights, please call or submit the evaluation form.



Avandia Heart Attack Danger

FDA Issues "Black Box" Warning for Popular Diabetes Drug

Avandia-RosiglitazoneThe FDA has issued a "Black Box" warning for Avandia. Avandia has come under fire for increasing the risk of heart attack. Avandia is a widely prescribed drug for Type II Diabetes. Of the approximately 6 million users of this Diabetes drug worldwide there are reports of perhaps as many as 200,000 Heart Attacks.

If you or someone you love has used Avandia and experienced any of the following symptoms we urge you to call today for a free consultation.

Special Alert May 18, 2011: FDA Announces Plan to Pull Avandia

FDA announced May 18 to the public new restrictions to the prescribing, dispensing, and use of Rosiglitazone-containing medications (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline [GSK]) as part of a Risk Evaluation and Mitigation Strategy (REMS). The new restrictions require healthcare providers, including Pharmacists and Patients to enroll in a special program in order to prescribe, dispense, and receive these drugs.

In addition, after November 18, 2011, Rosiglitazone medications will no longer be available through Retail Pharmacies. GlaxoSmithKline will withdraw Rosiglitazone drugs from the current supply chain and will provide Pharmacies with instructions on returning the medications.

To learn more about your legal rights, and further details about Avandia, please call or submit the evaluation form.



Widely used drug linked to Birth Defects

FDA Black Box Warning Issued for Depakote

Depakote WarningDepakote is a drug used in the treatment of Epilepsy and it is also prescribed for Convulsions, Depression, and Bipolar disorder.

Depakote is one of a class of drugs created from or involving Valproate; additional examples of Valproate based drugs include Stavzor, Depakene, and Depacon. The first of these drugs to be approved in the class of valproate based drugs was Depakene, which first obtained FDA approval in 1978.

In 2006 the FDA issued a "Black Box" warning for Depakote and additional studies in 2010 have increased the concerns as it is now suggested that by the time a woman realizes she is pregnant it may be too late to avert birth defects to the growing fetus. Some studies suggest perhaps a 20% increase in birth defect risk amongst women taking Depakote.

Birth Defect Risks:

  • Holes in the Heart
  • Extra Fingers and Toes
  • Cleft Palate
  • Abnormal Skull Formation
  • Spina Bifida
  • Urinary Tract Problems
  • Malformed Limbs

The FDA strengthened the wording of the birth defect warnings on packaging for Depakote and similar drugs based on Valproic Acid in December 2009. The FDA informed Health Care Professionals to warn all women who were of age to bear children and who were currently taking these drugs that use while pregnant could result in a wide range of birth defects in their children.

If you or a loved one have taken Depakote or other Valporate drugs for any reason and gave birth to a child with any of the listed symptoms you need to speak with a legal expert. If you are attempting to get pregnant or could become pregnant we urge you to consult with physicians (and do your own research!) to understand the risks of these medications.

If you or a loved one have been impacted by these serious health issues please contact MedRecallNews today. Call 1-866-321-3585 or submit the evaluation form.



MedRecallNews Updates

Who's Online

We have 15 guests online
MedRecall News is not a law firm or lawyer referral service and is not associated with pharmaceutical companies or the FDA. Certain cases may only be accepted based on federal and state statutes.